SOURCE: Alpharma Inc.

September 20, 2007 15:28 ET

Alpharma to Present at 2007 UBS Global Life Sciences Conference

BRIDGEWATER, NJ--(Marketwire - September 20, 2007) - Alpharma Inc. (NYSE: ALO), a leading global specialty pharmaceutical company, announced today that Alpharma's senior management will provide an overview of the company's business at the UBS Global Life Sciences Conference on Thursday, September 27, 2007 at 9:30AM Eastern Daylight Time.

This presentation will be audio webcast live and can be accessed through Alpharma's website, www.alpharma.com.

An archived version of the live presentation will be available until October 27, 2007 and can be accessed at the same location.

Alpharma press releases are also available at our website: http://www.alpharma.com.

Alpharma Inc. (NYSE: ALO) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN® product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Contact Information

  • Contact:
    Kathleen Makrakis
    VP, Investor Relations
    Email Contact
    908-566-3916